Farther Finance Advisors LLC Takes $707,000 Position in ASP Isotopes Inc. $ASPI

Key Points

• Farther Finance Advisors LLC has acquired a new stake in ASP Isotopes Inc., purchasing approximately 95,999 shares valued at around $707,000 during the second quarter.
• ASP Isotopes recently reported negative earnings per share of ($1.03), missing analyst expectations by a significant margin while also facing a negative return on equity of 239.22%.
• Analysts have set a buy rating for ASP Isotopes with a target price ranging from $7.75 to $11.00, reflecting investor confidence despite recent financial challenges.

Farther Finance Advisors LLC bought a new stake in shares of ASP Isotopes Inc. (NASDAQ:ASPI - Free Report) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 95,999 shares of the company's stock, valued at approximately $707,000. Farther Finance Advisors LLC owned approximately 0.11% of ASP Isotopes at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in shares of ASP Isotopes by 9.4% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 31,613 shares of the company's stock valued at $148,000 after purchasing an additional 2,709 shares in the last quarter. SBI Securities Co. Ltd. grew its stake in ASP Isotopes by 84.8% in the 1st quarter. SBI Securities Co. Ltd. now owns 9,370 shares of the company's stock valued at $44,000 after acquiring an additional 4,299 shares during the period. Rhumbline Advisers grew its stake in ASP Isotopes by 8.2% in the 1st quarter. Rhumbline Advisers now owns 65,326 shares of the company's stock valued at $306,000 after acquiring an additional 4,963 shares during the period. MetLife Investment Management LLC grew its stake in ASP Isotopes by 22.1% in the 1st quarter. MetLife Investment Management LLC now owns 31,732 shares of the company's stock valued at $149,000 after acquiring an additional 5,744 shares during the period. Finally, Deutsche Bank AG grew its stake in ASP Isotopes by 19.4% in the 1st quarter. Deutsche Bank AG now owns 40,092 shares of the company's stock valued at $188,000 after acquiring an additional 6,505 shares during the period. 16.80% of the stock is owned by hedge funds and other institutional investors.

ASP Isotopes Trading Down 4.0%

Shares of ASPI opened at $10.68 on Friday. ASP Isotopes Inc. has a 52-week low of $2.61 and a 52-week high of $11.86. The company has a quick ratio of 14.56, a current ratio of 14.72 and a debt-to-equity ratio of 3.53. The firm's fifty day moving average is $9.57 and its two-hundred day moving average is $7.50. The stock has a market cap of $981.60 million, a PE ratio of -17.51 and a beta of 3.35.

ASP Isotopes (NASDAQ:ASPI - Get Free Report) last announced its earnings results on Thursday, August 14th. The company reported ($1.03) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.11) by ($0.92). ASP Isotopes had a negative return on equity of 239.22% and a negative net margin of 2,181.62%.The business had revenue of $1.20 million for the quarter, compared to analyst estimates of $1.60 million. Research analysts forecast that ASP Isotopes Inc. will post -0.24 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Separately, Canaccord Genuity Group reissued a "buy" rating and issued a $11.00 price target on shares of ASP Isotopes in a research note on Wednesday, September 17th. Two research analysts have rated the stock with a Buy rating, According to MarketBeat, the company presently has a consensus rating of "Buy" and an average target price of $7.75.

Insiders Place Their Bets

In other ASP Isotopes news, CEO Paul Elliot Mann sold 81,077 shares of ASP Isotopes stock in a transaction on Tuesday, September 9th. The shares were sold at an average price of $8.39, for a total transaction of $680,236.03. Following the sale, the chief executive officer owned 8,084,191 shares of the company's stock, valued at $67,826,362.49. The trade was a 0.99% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, COO Robert Ainscow sold 8,438 shares of ASP Isotopes stock in a transaction on Monday, September 8th. The stock was sold at an average price of $8.53, for a total transaction of $71,976.14. Following the sale, the chief operating officer directly owned 1,411,554 shares in the company, valued at approximately $12,040,555.62. This trade represents a 0.59% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 245,591 shares of company stock valued at $2,139,790 in the last 90 days. 21.40% of the stock is owned by insiders.

ASP Isotopes Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.

Want to see what other hedge funds are holding ASPI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ASP Isotopes Inc. (NASDAQ:ASPI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.